178 related articles for article (PubMed ID: 30102605)
1. Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach.
Patel NM; Jo H; Eberhard DA; Yin X; Hayward MC; Stein MK; Hayes DN; Grilley-Olson JE
Appl Immunohistochem Mol Morphol; 2019; 27(10):764-772. PubMed ID: 30102605
[TBL] [Abstract][Full Text] [Related]
2. SAAS-CNV: A Joint Segmentation Approach on Aggregated and Allele Specific Signals for the Identification of Somatic Copy Number Alterations with Next-Generation Sequencing Data.
Zhang Z; Hao K
PLoS Comput Biol; 2015 Nov; 11(11):e1004618. PubMed ID: 26583378
[TBL] [Abstract][Full Text] [Related]
3. AbsCN-seq: a statistical method to estimate tumor purity, ploidy and absolute copy numbers from next-generation sequencing data.
Bao L; Pu M; Messer K
Bioinformatics; 2014 Apr; 30(8):1056-1063. PubMed ID: 24389661
[TBL] [Abstract][Full Text] [Related]
4. Clonality Inference from Single Tumor Samples Using Low-Coverage Sequence Data.
Donmez N; Malikic S; Wyatt AW; Gleave ME; Collins CC; Sahinalp SC
J Comput Biol; 2017 Jun; 24(6):515-523. PubMed ID: 28056180
[TBL] [Abstract][Full Text] [Related]
5. Accurity: accurate tumor purity and ploidy inference from tumor-normal WGS data by jointly modelling somatic copy number alterations and heterozygous germline single-nucleotide-variants.
Luo Z; Fan X; Su Y; Huang YS
Bioinformatics; 2018 Jun; 34(12):2004-2011. PubMed ID: 29385401
[TBL] [Abstract][Full Text] [Related]
6. TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.
Gray PN; Vuong H; Tsai P; Lu HM; Mu W; Hsuan V; Hoo J; Shah S; Uyeda L; Fox S; Patel H; Janicek M; Brown S; Dobrea L; Wagman L; Plimack E; Mehra R; Golemis EA; Bilusic M; Zibelman M; Elliott A
Oncotarget; 2016 Oct; 7(42):68206-68228. PubMed ID: 27626691
[TBL] [Abstract][Full Text] [Related]
7. Tumor Mutation Burden Computation in Two Pan-Cancer Precision Medicine Next-Generation Sequencing Panels.
Shu Y; Wu X; Shen J; Luo D; Li X; Wang H; Tang YT
J Comput Biol; 2020 Oct; 27(10):1553-1560. PubMed ID: 32311294
[TBL] [Abstract][Full Text] [Related]
8. Somatic point mutation calling in low cellularity tumors.
Kassahn KS; Holmes O; Nones K; Patch AM; Miller DK; Christ AN; Harliwong I; Bruxner TJ; Xu Q; Anderson M; Wood S; Leonard C; Taylor D; Newell F; Song S; Idrisoglu S; Nourse C; Nourbakhsh E; Manning S; Wani S; Steptoe A; Pajic M; Cowley MJ; Pinese M; Chang DK; Gill AJ; Johns AL; Wu J; Wilson PJ; Fink L; Biankin AV; Waddell N; Grimmond SM; Pearson JV
PLoS One; 2013; 8(11):e74380. PubMed ID: 24250782
[TBL] [Abstract][Full Text] [Related]
9. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of the JAX Cancer Treatment Profile™ for detection of clinically actionable mutations in solid tumors.
Ananda G; Mockus S; Lundquist M; Spotlow V; Simons A; Mitchell T; Stafford G; Philip V; Stearns T; Srivastava A; Barter M; Rowe L; Malcolm J; Bult C; Karuturi RK; Rasmussen K; Hinerfeld D
Exp Mol Pathol; 2015 Feb; 98(1):106-12. PubMed ID: 25562415
[TBL] [Abstract][Full Text] [Related]
11. Accurately estimating the length distributions of genomic micro-satellites by tumor purity deconvolution.
Wang Y; Zhang X; Xiao X; Zhang FR; Yan X; Feng X; Zhao Z; Guan Y; Wang J
BMC Bioinformatics; 2020 Mar; 21(Suppl 2):82. PubMed ID: 32164528
[TBL] [Abstract][Full Text] [Related]
12. Ploidy- and Purity-Adjusted Allele-Specific DNA Analysis Using CLONETv2.
Prandi D; Demichelis F
Curr Protoc Bioinformatics; 2019 Sep; 67(1):e81. PubMed ID: 31524989
[TBL] [Abstract][Full Text] [Related]
13. Somatic Tumor Variant Filtration Strategies to Optimize Tumor-Only Molecular Profiling Using Targeted Next-Generation Sequencing Panels.
Sukhai MA; Misyura M; Thomas M; Garg S; Zhang T; Stickle N; Virtanen C; Bedard PL; Siu LL; Smets T; Thijs G; Van Vooren S; Kamel-Reid S; Stockley TL
J Mol Diagn; 2019 Mar; 21(2):261-273. PubMed ID: 30576869
[TBL] [Abstract][Full Text] [Related]
14. Identification of Cancer Driver Genes from a Custom Set of Next Generation Sequencing Data.
Liu SH; Cheng WC
Methods Mol Biol; 2019; 1907():19-36. PubMed ID: 30542988
[TBL] [Abstract][Full Text] [Related]
15. A method to reduce ancestry related germline false positives in tumor only somatic variant calling.
Halperin RF; Carpten JD; Manojlovic Z; Aldrich J; Keats J; Byron S; Liang WS; Russell M; Enriquez D; Claasen A; Cherni I; Awuah B; Oppong J; Wicha MS; Newman LA; Jaigge E; Kim S; Craig DW
BMC Med Genomics; 2017 Oct; 10(1):61. PubMed ID: 29052513
[TBL] [Abstract][Full Text] [Related]
16. Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC.
Zhao X; Wang A; Walter V; Patel NM; Eberhard DA; Hayward MC; Salazar AH; Jo H; Soloway MG; Wilkerson MD; Parker JS; Yin X; Zhang G; Siegel MB; Rosson GB; Earp HS; Sharpless NE; Gulley ML; Weck KE; Hayes DN; Moschos SJ
PLoS One; 2015; 10(6):e0129280. PubMed ID: 26076459
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
18. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing.
Shen R; Seshan VE
Nucleic Acids Res; 2016 Sep; 44(16):e131. PubMed ID: 27270079
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
Krøigård AB; Thomassen M; Lænkholm AV; Kruse TA; Larsen MJ
PLoS One; 2016; 11(3):e0151664. PubMed ID: 27002637
[TBL] [Abstract][Full Text] [Related]
20. Targeted Next-Generation Sequencing in Molecular Subtyping of Lower-Grade Diffuse Gliomas: Application of the World Health Organization's 2016 Revised Criteria for Central Nervous System Tumors.
Carter JH; McNulty SN; Cimino PJ; Cottrell CE; Heusel JW; Vigh-Conrad KA; Duncavage EJ
J Mol Diagn; 2017 Mar; 19(2):328-337. PubMed ID: 28042970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
